CervoMed Inc (CRVO)
24.54
+0.92
(+3.90%)
USD |
NASDAQ |
May 10, 16:00
24.54
0.00 (0.00%)
After-Hours: 17:26
CervoMed 1 Year Total Returns (Daily): 302.7% for May 9, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 09, 2024 | 302.7% |
| May 08, 2024 | 326.8% |
| May 07, 2024 | 326.9% |
| May 06, 2024 | 325.7% |
| May 03, 2024 | 322.1% |
| May 02, 2024 | 305.4% |
| May 01, 2024 | 305.9% |
| April 30, 2024 | 321.7% |
| April 29, 2024 | 329.3% |
| April 26, 2024 | 319.0% |
| April 25, 2024 | 338.4% |
| April 24, 2024 | 304.2% |
| April 23, 2024 | 293.5% |
| April 22, 2024 | 287.0% |
| April 19, 2024 | 240.4% |
| April 18, 2024 | 268.7% |
| April 17, 2024 | 289.4% |
| April 16, 2024 | 286.6% |
| April 15, 2024 | 263.3% |
| April 12, 2024 | 301.8% |
| April 11, 2024 | 305.8% |
| April 10, 2024 | 332.5% |
| April 09, 2024 | 303.8% |
| April 08, 2024 | 304.7% |
| April 05, 2024 | 248.6% |
| Date | Value |
|---|---|
| April 04, 2024 | 274.7% |
| April 03, 2024 | 244.5% |
| April 02, 2024 | 256.0% |
| April 01, 2024 | 264.7% |
| March 28, 2024 | 219.6% |
| March 27, 2024 | 153.5% |
| March 26, 2024 | 146.6% |
| March 25, 2024 | 150.1% |
| March 22, 2024 | 150.0% |
| March 21, 2024 | 151.0% |
| March 20, 2024 | 188.6% |
| March 19, 2024 | 168.9% |
| March 18, 2024 | 141.9% |
| March 15, 2024 | 103.4% |
| March 14, 2024 | 86.97% |
| March 13, 2024 | 94.95% |
| March 12, 2024 | 93.61% |
| March 11, 2024 | 94.82% |
| March 08, 2024 | 81.06% |
| March 07, 2024 | 70.94% |
| March 06, 2024 | 73.96% |
| March 05, 2024 | 37.62% |
| March 04, 2024 | 34.45% |
| March 01, 2024 | 48.51% |
| February 29, 2024 | 59.29% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-95.28%
Minimum
Nov 15 2019
338.4%
Maximum
Apr 25 2024
-26.29%
Average
-54.33%
Median
Aug 17 2021
1 Year Total Returns (Daily) Benchmarks
| GlucoTrack Inc | 31.42% |
| Regen BioPharma Inc | -62.67% |
| AIM ImmunoTech Inc | -10.90% |
| Protalix BioTherapeutics Inc | -57.19% |
| Armata Pharmaceuticals Inc | 154.7% |